A usual adverse effect, osimertinib-induced loose stools, which is linked to the use of osimertinib, a precision cancer treatment, presents major difficulties for patients.everyday life can be disrupted, and well-being can be affected by this state, which requires immediate medical care intervention.It is essential for both patients and medical professionals to comprehend the reasons, manifestations, treatment, and preventive measures.

This article aims to offer a thorough manual for navigating osimertinib-induced loose stools, including insights into its effect, treatment, and possible remedies.Definition and reasons:osimertinib-induced loose stools, which is defined as the event of loose stools as a side effect, is linked to osimertinib, a drug that is employed for the treatment of NSCLC (NSCLC) with unique genetic alterations.

The precise origin of osimertinib-induced loose stools is not completely comprehended; however, it is believed to involve the drug's connection with the GI tract.potential reasons include:The probability of experiencing osimertinib-induced loose stools may be raised by several elements, including the individual's age, gender, and general state. Furthermore, certain way of living aspects, such as nutrition and fluid intake, may also affect the intensity of the loose stools experienced.